HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)
9.68
+0.04 (0.41%)
Apr 29, 2026, 3:00 PM CST
SHA:600829 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 883.88 | 1,235 | 1,100 | 1,314 | 1,181 | 800.49 |
Cash & Short-Term Investments | 883.88 | 1,235 | 1,100 | 1,314 | 1,181 | 800.49 |
Cash Growth | 18.54% | 12.33% | -16.32% | 11.25% | 47.59% | 91.18% |
Accounts Receivable | 4,565 | 4,086 | 4,350 | 4,385 | 4,168 | 4,182 |
Other Receivables | 20.01 | 61.11 | 53.13 | 64.96 | 47.26 | 40.91 |
Receivables | 4,585 | 4,147 | 4,403 | 4,450 | 4,215 | 4,222 |
Inventory | 1,282 | 1,230 | 1,101 | 1,115 | 1,074 | 1,105 |
Prepaid Expenses | - | 4.76 | 9.98 | 1.79 | 4.59 | 8.44 |
Other Current Assets | 119.19 | 75.27 | 72.83 | 42.8 | 71.01 | 48.78 |
Total Current Assets | 6,870 | 6,693 | 6,687 | 6,925 | 6,546 | 6,185 |
Property, Plant & Equipment | 318.09 | 318.06 | 335.85 | 346.13 | 367.81 | 410.84 |
Other Intangible Assets | 25.83 | 26.34 | 28.08 | 26.5 | 28.01 | 29.29 |
Long-Term Deferred Tax Assets | 87.17 | 83.43 | 67.45 | 67.69 | 64.25 | 67.15 |
Long-Term Deferred Charges | 8.01 | 8.93 | 10.48 | 11.2 | 11.81 | 12.08 |
Other Long-Term Assets | 44.28 | 44.96 | 37.42 | 50.3 | 40.54 | 43.14 |
Total Assets | 7,353 | 7,175 | 7,166 | 7,426 | 7,059 | 6,748 |
Accounts Payable | 2,939 | 2,836 | 2,781 | 2,914 | 2,614 | 2,478 |
Accrued Expenses | 15.87 | 45.82 | 34.24 | 44.73 | 50.24 | 30.72 |
Short-Term Debt | 706.8 | 679.4 | 839.22 | 962.08 | 1,198 | 1,233 |
Current Portion of Leases | 24.61 | 24.89 | 30.56 | 27.69 | 32.09 | 35.18 |
Current Income Taxes Payable | 57.19 | 26.96 | 25.84 | 43.33 | 27.38 | 34.92 |
Current Unearned Revenue | 15.76 | 23.97 | 15.12 | 15.99 | 11.45 | 13.3 |
Other Current Liabilities | 390.73 | 378.08 | 408.3 | 512.7 | 498.47 | 531.72 |
Total Current Liabilities | 4,150 | 4,015 | 4,134 | 4,521 | 4,431 | 4,357 |
Long-Term Leases | 23.78 | 28.08 | 30.37 | 29.41 | 38.48 | 59.59 |
Long-Term Unearned Revenue | 112.66 | 113.63 | 117.09 | 120.94 | 125.71 | 130.77 |
Long-Term Deferred Tax Liabilities | 2.97 | 3.31 | 3.7 | 4.05 | 4.51 | - |
Other Long-Term Liabilities | - | - | - | 0.14 | 0.57 | 1.56 |
Total Liabilities | 4,290 | 4,160 | 4,285 | 4,675 | 4,601 | 4,549 |
Common Stock | 579.89 | 579.89 | 579.89 | 579.89 | 579.89 | 579.89 |
Retained Earnings | 2,484 | 2,435 | 2,301 | 2,172 | 1,879 | 1,620 |
Total Common Equity | 3,063 | 3,015 | 2,881 | 2,751 | 2,459 | 2,200 |
Minority Interest | -0.04 | -0.04 | -0.04 | -0.04 | -1.06 | -1.02 |
Shareholders' Equity | 3,063 | 3,015 | 2,881 | 2,751 | 2,458 | 2,199 |
Total Liabilities & Equity | 7,353 | 7,175 | 7,166 | 7,426 | 7,059 | 6,748 |
Total Debt | 755.18 | 732.37 | 900.15 | 1,019 | 1,268 | 1,328 |
Net Cash (Debt) | 128.69 | 503.04 | 199.69 | 295.17 | -86.9 | -527.08 |
Net Cash Growth | - | 151.91% | -32.35% | - | - | - |
Net Cash Per Share | 0.22 | 0.87 | 0.34 | 0.51 | -0.15 | -0.91 |
Filing Date Shares Outstanding | 579.89 | 579.89 | 579.89 | 579.89 | 579.89 | 579.89 |
Total Common Shares Outstanding | 579.89 | 579.89 | 579.89 | 579.89 | 579.89 | 579.89 |
Working Capital | 2,719 | 2,678 | 2,553 | 2,404 | 2,115 | 1,829 |
Book Value Per Share | 5.28 | 5.20 | 4.97 | 4.74 | 4.24 | 3.79 |
Tangible Book Value | 3,038 | 2,989 | 2,853 | 2,725 | 2,431 | 2,171 |
Tangible Book Value Per Share | 5.24 | 5.15 | 4.92 | 4.70 | 4.19 | 3.74 |
Buildings | - | 357.93 | 372.04 | 372.04 | 374.91 | 374.93 |
Machinery | - | 153.62 | 145.84 | 147.21 | 146.43 | 149.73 |
Construction In Progress | - | 55.27 | 57.47 | 59.62 | 60.42 | 60.42 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.